Point-of-care ultrasound aids in the management of patient taking semaglutide before surgery: A case report
Here is how we approach UHC cases: Benefits verification
Effective strategies promote long-term success with weight loss or diabetes care
GLP-1 weight loss costs are expected to increase again between approximately 130 percent (low estimate) and nearly 200 percent (high estimate), by the end of the second quarter in fiscal year 2027, according to the departments budget request
As your body adjusts to these changes, temporary side effects can occur, particularly during the early stages of treatment or after dose increases
As with earlier GLP-1 agents, any sexual side effects will likely be dose-dependent, reversible, and patient-specific